J. Nitta

Published guidelines versus real‐life practice in the diagnosis and treatment of essential thrombocythemia

Erica A. Peterson, L. Zypchen, L. Foltz, 2011, American journal of hematology.

Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

K. Sullivan, J. Kanda, D. Niedzwiecki, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Flow cytometry‐based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia

D. Hogge, Hyun Pyo Kim, L. Bernard, 2012, Cytometry. Part B, Clinical cytometry.

Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.

J. Kuruvilla, D. Hogge, Clayton A. Smith, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)

J. Connors, M. Power, R. Broady, 2011, Leukemia & lymphoma.

Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia

M. Seftel, A. Daly, K. Paulson, 2018, Leukemia & lymphoma.

Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.

D. Hogge, Clayton A. Smith, S. Nantel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.

M. Power, Yunfeng Dai, D. Hogge, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.

D. Horsman, D. Hogge, Y. Chalandon, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML

M. Power, S. Nantel, K. Song, 2008, Bone Marrow Transplantation.

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)

J. Connors, M. Power, R. Broady, 2011, Leukemia & lymphoma.